Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders4th edn. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Lampe L A, Slade T, Issakidis C, Andrews G. Social phobia in the National Survey of Mental Health and Well-Being. Psychological Medicine, in press
   Google Scholar
• Magee W J, Eaton W W, Wittchen H U, et al. Agoraphobia, simple phobia and social phobia in the National Comorbidity Survey. Archives of General Psychiatry 1996; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Wittchen H U, Beloch E. The impact of social phobia on quality of life. International Clinical Psychopharmacology 1996; 11: 15–23
   PubMed Web of Science ®Google Scholar
• Brunello N, Den Boer J A, Judd L L, et al. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. Journal of Affective Disorders 2000; 60: 61–74
   PubMed Web of Science ®Google Scholar
• Feske U, Perry K J, Chambless D L, et al. Avoidant personality disorder as a predictor for treatment outcome among generalized social phobics. Journal of Personality Disorders 1996; 10: 174–184
   Web of Science ®Google Scholar
• Rapee R M, Heimberg R G. A cognitive-behavioral model of anxiety in social phobia. Behaviour Research and Therapy 1997; 35: 741–756
   PubMed Web of Science ®Google Scholar
• Scholing A, Emmelkamp PM G. Treatment of generalized social phobia: Results at long-term follow-up. Behaviour Research and Therapy 1996; 34: 447–452
   PubMedGoogle Scholar
• Fedoroff I C, Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. Journal of Clinical Psychopharmacology 2001; 21: 311–324
   PubMed Web of Science ®Google Scholar
• Schneier F B. Treatment of social phobia with antidepressants. Journal of Clinical Psychiatry 2001; 62: 43–49
   PubMedGoogle Scholar
• Liebowitz M R, Schneier F, Campeas R, et al. Phenelzine vs. atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry 1992; 49: 290–300
   PubMed Web of Science ®Google Scholar
• Heimberg R G, Liebowitz M R, Hope D A, et al. Cognitive behavioral group therapy vs. phenelzine therapy for social phobia 12-week outcome. Archives of General Psychiatry 1998; 55: 1133–1141
   PubMed Web of Science ®Google Scholar
• Julien R M. Drugs used to treat depression. A primer of drug action. Freeman, New York 2001; 283–312
   Google Scholar
• Noyes R, Jr, Moroz G, Davidson J R, et al. Moclobemide in social phobia: a controlled dose–response trial. Journal of Clinical Psychopharmacology 1997; 17: 247–254
   PubMed Web of Science ®Google Scholar
• Schneier F R, Goetz D, Campeas R, et al. Placebo-controlled trial of moclobemide in social phobia. British Journal of Psychiatry 1998; 172: 70–77
   PubMed Web of Science ®Google Scholar
• Lydiard R B. The role of drug therapy in social phobia. Journal of Affective Disorders 1998; 50: S35–S39
   Google Scholar
• Van der Linden GJ H, Stein D J, van Balkom AJ L. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 2000; 15: S15–S23
   PubMedGoogle Scholar
• Baldwin D, Bobes J, Stein D J, et al. Paroxetine in social phobia/social anxiety disorder: Randomised, double-blind, placebo-controlled study. British Journal of Psychiatry 1999; 175: 120–126
   PubMed Web of Science ®Google Scholar
• Stein M B, Liebowitz M R, Lydiard B. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomised controlled trial. Journal of the American Medical Association 1998; 280: 708–713
   PubMed Web of Science ®Google Scholar
• Stein M B, Fyer A J, Davidson JR T, et al. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. American Journal of Psychiatry 1999; 156: 756–760
   PubMed Web of Science ®Google Scholar
• Van Vliet I M, den Boer J A, Westenberg H G. Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology 1994; 115: 128–134
   PubMed Web of Science ®Google Scholar
• Van Ameringen M A, Lane R M, Walker J R, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. American Journal of Psychiatry 2001; 158: 275–281
   PubMed Web of Science ®Google Scholar
• Stein D J, Versiani M, Hair T, Kumar R. Efficacy of paroxetine for relapse prevention in social anxiety disorder. Archives of General Psychiatry 2002; 59: 1111–1118
   PubMed Web of Science ®Google Scholar
• Versiani M, Nardi A E, Mundim F D, et al. The long-term treatment of social phobia with moclobemide. International Clinical Psychopharmacology 1996; 11(Suppl. 3)83–88
   PubMedGoogle Scholar
• Versiani M, Amrein R, Montgomery S A. Social phobia – long-term treatment outcome and prediction of response – a moclobemide study. International Clinical Psychopharmacology 1997; 12: 239–254
   PubMed Web of Science ®Google Scholar
• Davidson JR T. Pharmacotherapy of social anxiety disorder. Journal of Clinical Psychiatry 1998; 59: 47–51
   Google Scholar
• Stein M B, Chartier M J, Hazen A, et al. Paroxetine in the treatment of generalized social phobia: Open-label treatment and double-blind placebo-controlled discontinuation. Journal of Clinical Psychopharmacology 1996; 16: 218–222
   PubMed Web of Science ®Google Scholar
• Heimberg R G, Salzman D G, Holt C S, Blendell K A. Cognitive behavioral group treatment for social phobia: Effectiveness at five-year follow-up. Cognitive Therapy and Research 1993; 17: 325–339
   Web of Science ®Google Scholar
• Heimberg R G, Dodge C S, Hope D A, et al. Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control. Cognitive Therapy and Research 1990; 14: 1–23
   Web of Science ®Google Scholar
• Heimberg R G. Cognitive-behavioral therapy for social anxiety disorder: Current status and future directions. Biological Psychiatry 2002; 51: 101–108
   PubMed Web of Science ®Google Scholar
• Gould R A, Buckminster S, Pollack M H, et al. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clinical Psychology Science and Practice 1997; 4: 291–306
   Web of Science ®Google Scholar
• Turner S M, Beidel D C, Wolff P L, et al. Clinical features affecting treatment outcome in social phobia. Behaviour Research and Therapy 1996; 34: 795–804
   PubMed Web of Science ®Google Scholar
• Stravynski A, Greenberg D. The treatment of social phobia: a critical assessment. Acta Psychiatrica Scandinavica 1998; 98: 171–181
   PubMedGoogle Scholar
• Clark D B, Agras W S. The assessment and treatment of performance anxiety in musicians. American Journal of Psychiatry 1991; 148: 598–605
   PubMed Web of Science ®Google Scholar
• Falloon I R, Lloyd G G, Harpin R E. The treatment of social phobia: Real-life rehearsal with nonprofessional therapists. Journal of Nervous and Mental Disease 1981; 169: 180–184
   PubMed Web of Science ®Google Scholar
• Gelertner C S, Uhde T W, Cimbolic P, et al. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Archives of General Psychiatry 1991; 48: 938–945
   PubMedGoogle Scholar
• Haug T, Blomhoff S, Hellstrom K, et al. Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomized controlled trial. British Journal of Psychiatry 2003; 182: 312–318
   PubMed Web of Science ®Google Scholar
• Oei TP S, Yeoh AE O. Pre-existing antidepressant medication and the outcome of group cognitive-behavioural therapy. Australian and New Zealand Journal of Psychiatry 1999; 33: 70–76
   PubMed Web of Science ®Google Scholar
• Oei TP S, Llamas M, Evans L. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy with panic disorder with agoraphobia patients?. Behaviour Research and Therapy 1997; 35: 851–857
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Composite international diagnostic interview, version 2.1. (12-month). WHO, Geneva 1997
   Google Scholar
• Slade T, Peters L, Schneiden V, Andrews G. The International Personality Disorders Examination Questionnaire: Preliminary data on its utility as a screener for anxious personality disorder. International Journal of Methods in Psychiatric Research 1998; 7: 84–88
   Google Scholar
• Andrews G, Crino R, Hunt C, Lampe L, Page A. The treatment of anxiety disorders: clinician's guide and patient manuals. Cambridge University Press, New York 1994
   Google Scholar
• Mattick R, Peters L. Treatment of severe social phobia: Effects of guided exposure with and without cognitive restructuring. Journal of Consulting and Clinical Psychology 1988; 56: 251–160
   PubMed Web of Science ®Google Scholar
• Mattick R P, Peters L, Clarke J C. Exposure and cognitive restructuring for social phobia: a controlled study. Behavior Therapy 1989; 20: 3–23
   Web of Science ®Google Scholar
• Hunt C, Andrews G. Long-term outcome of panic disorder and social phobia. Journal of Anxiety Disorders 1998; 12: 395–406
   PubMedGoogle Scholar
• Mattick R P, Clarke J C. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behaviour Research and Therapy 1998; 36: 455–470
   PubMed Web of Science ®Google Scholar
• Cox B J, Ross L, Swinson R P, Direnfeld D M. A comparison of social phobia outcome measures in cognitive-behavioral group therapy. Behavior Modification 1998; 22: 285–297
   PubMed Web of Science ®Google Scholar
• Watson D, Friend R. Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology 1969; 33: 448–457
   PubMed Web of Science ®Google Scholar
• Eysenck H J, Eysenck S B. Manual of the Eysenck Personality Questionnaire. Hodder and Stoughton, London 1975
   Google Scholar
• Lovibond S H, Lovibond P F. Manual for the Depression Anxiety Stress Scales2nd edn. Psychology Foundation, Sydney 1995
   Google Scholar
• Ware J E, Kosinski M, Keller S D. A 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Medical Care 1996; 34: 220–233
   PubMed Web of Science ®Google Scholar
• Glass G V, McGaw B, Smith M L. Meta-analysis in social research. Sage, London 1981
   Google Scholar
• Heimberg R G, Mueller G P, Holt C S, Hope D A, Liebowitz M R. Assessment of anxiety in social interaction and being observed by others: the social interaction anxiety scale and the social phobia scale. Behavior Therapy 1992; 23: 53–73
   Web of Science ®Google Scholar
• Cohen J. Quantitative methods in psychology: a power primer. Psychological Bulletin 1992; 112: 155–159
   PubMed Web of Science ®Google Scholar